CDMO Services
Cell & Gene Therapy

Partner focused. Patient driven.

Your global provider of tailored CGT solutions.

Let’s talk
About Us

C3i has built a one-stop shop in the development chain of Cell & Gene Therapy.

We work closely with our clients to manufacture products destined for patients all over the world. C3i prides itself on delivering, on time, quality results on behalf of its clients and for patients, advanced cell and gene products that meet regulatory requirements around the world.

Our Purpose

We work with our clients to ensure we put patients first. We are driven to perform our best knowing that the cells in our hands may be the patient's only chance at survival.

Our People

We are dedicated and highly trained personnel with over 15 years of experience in cell therapy and cGMP manufacturing.

Our Facility

C3i is the only fully validated cGMP center in Canada compliant with FDA, EMA, and Health Canada regulations with commercial capacity.

News

Read the latest news

Learn more about how C3i takes part in the development of new cell and gene therapies.
  • May 11, 2025

    C3i at ISCT 2025: An International Showcase for Our CDMO Capabilities

    A strategic gathering at the crossroads of innovation, regulation, and global partnerships From May 7 to 10, 2025, C3i participated in the International Society for Cell & Gene Therapy (ISCT), a major global conference held this year in New Orleans. Bringing together leading experts and organizations in the field, ISCT serves as a key hub […]

    Read More
  • May 09, 2025

    C3i Wins the 2025 Orchidée Innovation Award at the ESTim Gala

    A recognition of innovation serving health and the community C3i Center is proud to have received the Prix Orchidée Innovation 2025, presented by the Chambre de commerce de l’Est de Montréal (CCEM) during the ESTim Gala held on May 8. This prestigious award celebrates our ability to turn bold ideas into tangible solutions that advance […]

    Read More
  • May 01, 2025

    C3i at Effervescence Montréal 2025: A Must-Attend Event for Innovative Therapies

    An active presence at the heart of discussions on regenerative medicine On April 30, Yvan Côté, President and CEO of C3i, took part in Effervescence Montréal 2025, a key event bringing together key players from research, innovation, and the life sciences industry. Organized by ThéCell – Québec’s Cell, Tissue and Gene Therapy Network, this year’s […]

    Read More